$1.61
-0.03-1.83%
Last update: 12:44 PM
15 minutes delayed
Comments
Loading...
Coherus BioSciences
CHRSNASDAQ
Coherus BioSciences (NASDAQ:CHRS) Stock, Earnings Estimates, EPS, And Revenue
Coherus BioSciences reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Aug 5
EPS Estimate
$-0.160
Quarterly Revenue Estimate
$64.2M
Annual Revenue
(as of Mar 31)
(as of Mar 31)
$301.9M
Analyze the earnings history of Coherus BioSciences using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| CHRS | Coherus BioSciences | -$0.38 | -$0.16 | — | — | $58.72M | $64.16M | — | — | 08/05/2024 | Get Alert |
| CHRS | Coherus BioSciences | -$0.75 | -$0.24 | -$0.32 | -33.33% | $32.44M | $80.25M | $77.06M | -3.97% | 05/09/2024 | Get Alert |
| CHRS | Coherus BioSciences | -$0.60 | -$0.12 | -$0.62 | -416.67% | $45.35M | $96.40M | $91.52M | -5.06% | 03/13/2024 | Get Alert |
| CHRS | Coherus BioSciences | -$0.96 | -$0.31 | -$0.27 | 12.90% | $45.42M | $83.56M | $74.57M | -10.76% | 11/06/2023 | Get Alert |
| CHRS | Coherus BioSciences | -$0.47 | -$0.52 | -$0.38 | 26.92% | $60.15M | $50.83M | $58.72M | 15.51% | 08/02/2023 | Get Alert |
| CHRS | Coherus BioSciences | -$1.00 | -$0.57 | -$0.75 | -31.58% | $60.12M | $47.44M | $32.44M | -31.63% | 05/08/2023 | Get Alert |
| CHRS | Coherus BioSciences | -$0.46 | -$0.84 | -$0.60 | 28.57% | $73.37M | $51.22M | $45.35M | -11.46% | 03/06/2023 | Get Alert |
| CHRS | Coherus BioSciences | -$0.34 | -$0.57 | -$0.96 | -68.42% | $82.50M | $56.91M | $45.42M | -20.18% | 11/08/2022 | Get Alert |
| CHRS | Coherus BioSciences | -$0.36 | -$0.65 | -$0.47 | 27.69% | $87.64M | $61.31M | $60.15M | -1.89% | 08/04/2022 | Get Alert |
| CHRS | Coherus BioSciences | $0.01 | -$0.48 | -$1.00 | -108.33% | $83.03M | $68.95M | $60.12M | -12.81% | 05/05/2022 | Get Alert |
| CHRS | Coherus BioSciences | $0.23 | -$0.51 | -$0.46 | 9.80% | $110.42M | $85.81M | $73.37M | -14.50% | 02/17/2022 | Get Alert |
| CHRS | Coherus BioSciences | $0.47 | -$0.22 | -$0.34 | -54.55% | $113.55M | $91.31M | $82.50M | -9.65% | 11/08/2021 | Get Alert |
| CHRS | Coherus BioSciences | $0.81 | -$0.17 | -$0.36 | -111.76% | $135.67M | $89.81M | $87.64M | -2.41% | 08/05/2021 | Get Alert |
| CHRS | Coherus BioSciences | $0.48 | $0.06 | $0.01 | -83.33% | $116.18M | $96.00M | $83.03M | -13.51% | 05/06/2021 | Get Alert |
| CHRS | Coherus BioSciences | $0.53 | $0.23 | $0.23 | 0.00% | $123.86M | $115.12M | $110.42M | -4.08% | 02/24/2021 | Get Alert |
| CHRS | Coherus BioSciences | $0.63 | $0.41 | $0.47 | 14.63% | $111.68M | $122.88M | $113.55M | -7.59% | 11/05/2020 | Get Alert |
| CHRS | Coherus BioSciences | $0.32 | $0.33 | $0.81 | 145.45% | $83.43M | $104.95M | $135.67M | 29.27% | 08/06/2020 | Get Alert |
| CHRS | Coherus BioSciences | -$0.29 | $0.56 | $0.48 | -14.29% | $37.10M | $119.52M | $116.18M | -2.79% | 05/07/2020 | Get Alert |
| CHRS | Coherus BioSciences | -$0.92 | $0.72 | $0.53 | -26.39% | $0.00 | $123.01M | $123.86M | 0.69% | 02/27/2020 | Get Alert |
| CHRS | Coherus BioSciences | -$0.87 | $0.51 | $0.63 | 23.53% | $0.00 | $101.37M | $111.68M | 10.17% | 11/06/2019 | Get Alert |
| CHRS | Coherus BioSciences | -$0.68 | $0.08 | $0.32 | 300.00% | $0.00 | $75.49M | $83.43M | 10.52% | 08/01/2019 | Get Alert |
Coherus BioSciences (CHRS) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Mar 2024 | 2024-05-09 | $-0.32 | $-0.24 | -33.3 % |
| Dec 2023 | 2024-03-13 | $-0.62 | $-0.12 | -416.7 % |
| Sep 2023 | 2023-11-06 | $-0.27 | $-0.31 | 12.9 % |
| Jun 2023 | 2023-08-02 | $-0.38 | $-0.52 | 26.9 % |
Coherus BioSciences (CHRS) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Mar 2024 | 2024-05-09 | $77.06M | $80.25M | -3.97 % |
| Dec 2023 | 2024-03-13 | $91.52M | $96.40M | -5.06 % |
| Sep 2023 | 2023-11-06 | $74.57M | $83.56M | -10.8 % |
| Jun 2023 | 2023-08-02 | $58.72M | $50.83M | 15.5 % |
FAQ
When is Coherus BioSciences (NASDAQ:CHRS) reporting earnings?
Coherus BioSciences (CHRS) is scheduled to report earnings on August 5, 2024. The last reported earnings were for reported on May 9, 2024 for Q1.
What were the latest earnings per share (EPS) for Coherus BioSciences (NASDAQ:CHRS)?
The Actual EPS was $-0.32, which missed the estimate of $-0.24.
What were Coherus BioSciences’s (NASDAQ:CHRS) revenues?
The Actual Revenue was $77.1M, which missed the estimate of $80.3M.
Browse earnings estimates, EPS, and revenue on all stocks.